#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Spina bifida Arteriosclerosis Pelizaeus-Merzbacher disease Primary biliary cholangitis Pulmonary alveolar haemorrhage Kaposi's sarcoma Bulbospinal muscular atrophy congenital Selective polysaccharide antibody deficiency Metachromatic leukodystrophy Alport's syndrome Cerebral haemorrhage Microvillous inclusion disease Alpha-1 antitrypsin deficiency Systemic candida Primary adrenal insufficiency More trials…

    Learn about Rare Diseases

    Richter’s syndrome – Treatment Systemic mastocytosis Hepatoblastoma Fragile X syndrome – Diagnostics Biotinidase deficiency Splenic marginal zone lymphoma Methylmalonic acidaemia Pulmonary fibrosis – Treatment Castleman’s disease – Trials in Disease Myelodysplastic syndrome with excess blasts – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mitoxantrone Hydrochloride Fludrocortisone Remestemcel Bidridistrogene Xeboparvovec Dazucorilant Axicabtagene Ciloleucel BGB-16673 AZD3632 Ethambutol Hydrochloride Goserelin Acetate Azelastine Hydrochloride Rbd4059 Isoflurane L-Ascorbic Acid Pralsetinib Pegaspargase Daunorubicin Anthoxanthum Odoratum Human Von Willebrand Factor Prasugrel More therapies…

    Learn about Your Condition

    Dry mouth Acute promyelocytic leukaemia Sarcoma Sleep disorder KBG syndrome Herpes zoster Postprandial hypoglycaemia Merycism Fracture infection Ear discomfort Eye inflammation Tetanus Genital herpes Obesity Embolism venous More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Study on the Effectiveness and Safety of High-Dose Rifampicin, Moxifloxacin, and Linezolid for Patients with Pulmonary Tuberculosis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pulmonary tuberculosis
    Investigated Drugs:
    • Moxifloxacin Hydrochloride
    • Linezolid
    • Ethambutol Hydrochloride
    Spain

  • Study Comparing Rifampicin, Isoniazid, and Rifapentine Regimens for Treating Latent Tuberculosis in Patients with End-Stage Kidney Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Latent tuberculosis
    • End stage renal disease
    Investigated Drugs:
    • Pyridoxine
    • Rifapentine
    • Isoniazid
    Spain

  • Study on Vancomycin Hydrochloride for Treating Serious Infections in Critically Ill Adults Using a Precision Dosing Tool

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Vancomycin Hydrochloride
    Estonia

  • Study on the Safety and Effectiveness of TP-102 for Treating Diabetic Foot Infections in Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic foot infection
    Investigated Drugs:
    • F1245/05
    • F125/10
    • F44/10
    Poland

  • Study on the Effectiveness of Povidone-Iodine for Nasal Decolonization in Patients with MRSA

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Povidone, Iodinated
    France

  • Study on the Safety of Ceftolozane and Tazobactam for Children with Hospital-Acquired Pneumonia

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Ceftolozane
    • Tazobactam
    Estonia Greece Spain
Previous Page
1 … 43 44 45 46 47 48
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!